Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Surveillance of Summer Febrile Syndromes of Viral Origin in South of France

This study has been completed.
Information provided by (Responsible Party):
Assistance Publique Hopitaux De Marseille Identifier:
First received: February 11, 2009
Last updated: August 28, 2014
Last verified: August 2014
The aim is to document viral etiologies of isolated fevers and inlfuenza-like syndromes during summertime in South of France in order to better understand the role of known vector-borne viruses such as Toscana virus, West Nile virus during seasonal activity of the arthropod vector. In each of the four cities, a network of general practitioners will be associated in the project to recruit patients who are not hospitalized. The combined involvement of infectious disease specialists and general practitioner will augment the range of patients (mild disease and sever cases) in the study.

Condition Intervention
Summer Febrile Syndromes of Viral Origin

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention

Resource links provided by NLM:

Further study details as provided by Assistance Publique Hopitaux De Marseille:

Primary Outcome Measures:
  • to document viral etiologies of isolated fevers and inlfuenza-like syndromes during summertime in South of France [ Time Frame: 3 years ]

Secondary Outcome Measures:
  • Identification and characterization of emergent viruses responsible for estival fever in the south of France [ Time Frame: 3years ]

Enrollment: 90
Study Start Date: February 2009
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: BLOOD DRAW
    specific interview, sequential blood collection to allow virus isolation, molecular and serological diagnostics in patients

Ages Eligible for Study:   5 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Old: equal to or higher than 5 years Living in the south of France, without voyage abroad in the 2 weeks preceding inclusion Presenting a fever or a syndrome pseudogripal since less than 7 days without diagnostic orientation nor infectious pathology of body,
  • Affiliated with a mode of social security
  • After obtaining free and informed of the written assent

Exclusion Criteria:

  • Subject whose adhesion with the protocol is improbable according to the investigator
  • Expectant mother
  • Subject taking part in another clinical trial or in period of exclusion of a preceding clinical trial infectious
  • Pathology of body requiring a specific treatment
  • Discovered after inclusion d' a pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00842166

Service des Maladies Infectieuses et Tropicales de l'Hôpital Nord, AP-HM
Marseille, France
Sponsors and Collaborators
Assistance Publique Hopitaux De Marseille
Principal Investigator: REMI CHARREL Assistance Publique Hopitaux De Marseille
  More Information

Responsible Party: Assistance Publique Hopitaux De Marseille Identifier: NCT00842166     History of Changes
Other Study ID Numbers: 2008 19
Study First Received: February 11, 2009
Last Updated: August 28, 2014

Additional relevant MeSH terms:
Pathologic Processes
Body Temperature Changes
Signs and Symptoms processed this record on May 25, 2017